Molecular docking and toxicity studies of nerve agents against acetylcholinesterase (AChE)

References

• Figueiredo TH, Apland JP, Braga MFM, et al. Acute and long‐term consequences of exposure to organophosphate nerve agents in humans. Epilepsia. 2018;59 Suppl 2(Suppl 2):92–99. doi:10.1111/epi.14500.
   PubMedGoogle Scholar
• https://emergency.cdc.gov/agent., accessed on 19 Jan 2023.
   Google Scholar
• Hrvat NM, Kovarik Z. Counteracting poisoning with chemical warfare nerve agents. Arh Hig Rada Toksikol. 2020;71(4):266–284. doi:10.2478/aiht-2020-71-3459.
   PubMed Web of Science ®Google Scholar
• Prathap Yadav RS, Vijetha Shenoy B, Kumar N, et al. In vivo acetylcholinesterase activity and antioxidant property of cucurbita pepo ethanolic extract in alzheimer’s disease induced by aluminium chloride in sprague dawley rat model. RJPT. 2023;16(3):1065–1071. doi:10.52711/0974-360X.2023.00178.
   Google Scholar
• Athitya LS, Bharath VMV, Nellore J, et al. Screening of gracilaria corticata extracts for acetylcholinesterase inhibitory activity. Rese J Pharm Technol. 2018;11(9):3848–3850. doi:10.5958/0974-360X.2018.00704.7.
   Google Scholar
• Dhananjayan K, Sumathy A, Palanisamy S. Molecular docking studies and in-vitro acetylcholinesterase inhibition by terpenoids and flavonoids. Asian J Res Chem. 2013;6(11):1011–1017.
   Google Scholar
• Sahoo S, Rahman ML, Mitra S, et al. In silico investigation of methyl parathion and diazinon with different metabolic protein in Drosophila melanogaster. RJPT. 2021;14(7):3794–3798. doi:10.52711/0974-360X.2021.00657.
   Google Scholar
• Thomas, Reshma, Hari, R., Joy, Josna, et al. ‘In silico docking approach of coumarin derivatives as an aromatase antagonist’’. Res. J. Pharm. Technol. 8.12 (2015): 1673–1678. doi:10.5958/0974-360X.2015.00302.9.
   Google Scholar
• Ramachandran V, Khan I, Sugumar S, et al. Antioxidant, anti-inflammatory and anticholinergic action of berberine attenuates diabetic encephalopathy: behavioral and biochemical evidences. Res J Pharm Technol. 2020;13(10):4550–4556. doi:10.5958/0974-360X.2020.00802.1.
   Google Scholar
• Sravani M, et al. Insilico analysis and docking of tacrine and donepezil derivatives targeting Histamine-N-Methyltransferase and acetyl cholinesterase protein respectively for alzheimer’s disease. Res J Pharm Technol. 2013;6(1):86–89.
   Google Scholar
• Ko Latt K, Reng Liana S, Poddar S, et al. Pesticide utilization in Myanmar and effects on human health and environment. RJPT. 2023;16(2):681–685. doi:10.52711/0974-360X.2023.00116.
   Google Scholar
• Lal CLV, Chandan RS, Maruthi R, et al. Bio-analytical method development and validation of dichlorvos pesticide by rp-uflc method. Res J Pharm Technol. 2020;13(8):3725–3728. doi:10.5958/0974-360X.2020.00659.9.
   Google Scholar
• Skaria TG, Reddy BS, Vidya RVS, et al. Risk factors for the development of complications in organophosphate and carbamate poisoning. Res J Pharm Technol. 2020;13(1):361–367. doi:10.5958/0974-360X.2020.00072.4.
   Google Scholar
• El Sayed S, Pascual L, Agostini A, et al. A chromogenic probe for the selective recognition of sarin and soman mimic DFP. ChemistryOpen. 2014;3(4):142–145. doi:10.1002/open.201402014.
   PubMed Web of Science ®Google Scholar
• Jang C, Yadav DK, Subedi L, et al. Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay. Sci Rep. 2018;8(1):14921. doi:10.1038/s41598-018-33354-6.
   PubMedGoogle Scholar
• Cheung J, Rudolph MJ, Burshteyn F, et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem. 2012;55(22):10282–10286. doi:10.1021/jm300871x.
   PubMed Web of Science ®Google Scholar
• Ali Marzouk H, Wibowo S, Khotimah H, et al. Molecular interaction of centella asiatica bioactive compounds and donepezil on alzheimer’s protein through in silico studies. RJPT. 2022;15(11):4887–4896. doi:10.52711/0974-360X.2022.00821.
   Google Scholar
• Xu X, Zou X. Dissimilar ligands bind in a similar fashion: a guide to ligand binding-mode prediction with application to CELPP studies. Int J Mol Sci. 2021;22(22):12320. doi:10.3390/ijms222212320.
   PubMed Web of Science ®Google Scholar
• Kareem RT, Abedinifar F, Mahmood EA, et al. The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s agents: highlights from 2010 to 2020. RSC Adv. 2021;11(49):30781–30797. doi:10.1039/d1ra03718h.
   PubMed Web of Science ®Google Scholar
• Owoloye AJ, et al. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors. bioRxiv. 2022; doi:10.1371/journal.pone.0268269.
   Google Scholar
• Kumar SP, Patel CN, Rawal RM, et al. Energetic contributions of amino acid residues and its cross‐talk to delineate ligand‐binding mechanism. Proteins. 2020;88(9):1207–1225. doi:10.1002/prot.25894.
   PubMed Web of Science ®Google Scholar
• Wiesner J, Kriz Z, Kuca K, et al. Acetylcholinesterases–the structural similarities and differences. J Enzyme Inhib Med Chem. 2007;22(4):417–424. doi:10.1080/14756360701421294.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Cusack B, Davies MP, et al. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. Biochemistry. 2003;42(18):5438–5452. doi:10.1021/bi027065u.
   PubMed Web of Science ®Google Scholar
• Radić Z, Taylor P. Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex. J Biol Chem. 2001;276(7):4622–4633. doi:10.1074/jbc.m006855200.
   PubMed Web of Science ®Google Scholar
• Moraga-Nicolás F, Jara C, Godoy R, et al. Rhodolirium andicola: a new renewable source of alkaloids with acetylcholinesterase inhibitory activity, a study from nature to molecular docking. Revista Brasileira de Farmacognosia. 2018;28(1):34–43. doi:10.1016/j.bjp.2017.11.009.
   Google Scholar
• Wojtunik-Kulesza KA, Targowska-Duda K, Klimek K, et al. Volatile terpenoids as potential drug leads in alzheimer’s disease. Open Chemistry. 2017;15(1):332–343. doi:10.1515/chem-2017-0040.
   Web of Science ®Google Scholar
• AR, AK, KG, et al. Role of aromatic amino acids in stabilizing organophosphate and human acetylcholinesterase complex. JCPR. 2015;5(4):1632–1639. doi:10.33786/JCPR.2015.v05i04.006.
   Google Scholar
• Zheng Q, Chu H, Niu R, et al. Theoretical studies of interaction models of human acetylcholine esterase with different inhibitors. Sci China Ser B-Chem. 2009;52(11):1911–1916. doi:10.1007/s11426-009-0281-y.
   Web of Science ®Google Scholar
• Ordentlich A, Barak D, Sod-Moriah G, et al. The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers. Chem Biol Interact. 2005;157-158:191–198. doi:10.1016/j.cbi.2005.10.026.
   PubMed Web of Science ®Google Scholar
• Kua J, Zhang Y, Eslami AC, et al. Studying the roles of W86, E202, and Y337 in binding of acetylcholine to acetylcholinesterase using a combined molecular dynamics and multiple docking approach. Protein Sci. 2003;12(12):2675–2684. doi:10.1110/ps.03318603.
   PubMed Web of Science ®Google Scholar
• Shafferman A, Kronman C, Flashner Y, et al. Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. J Biol Chem. 1992;267(25):17640–17648. doi:10.1016/S0021-9258(19)37091-7.
   PubMed Web of Science ®Google Scholar
• Mohamed RA, Ong KK, Halim NA, et al. 4-Hydroxybenzohydrazide: a potential reactivator for Malathion-inhibited human acetylcholinesterase. IOP Conf Ser: mater Sci Eng. 2021;1051(1):012021. doi:10.1088/1757-899X/1051/1/012021.
   Google Scholar
• Ranjan A, Chauhan A, Jindal T. In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates. Environ Toxicol Pharmacol. 2018;57:131–140. doi:10.1016/j.etap.2017.12.014.
   PubMed Web of Science ®Google Scholar
• Sim VM, Stubbs JL. 1960). VX percutaneous studies in man. US Army Chemical Research and Development Laboratories Technical Report, CRDLR, 3015
   Google Scholar
• Attique SA, Hassan M, Usman M, et al. A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. Int J Environ Res Public Health. 2019;16(6):923. doi:10.3390/ijerph16060923.
   PubMed Web of Science ®Google Scholar
• Giacoppo JOS, C C França T, Kuča K, et al. Molecular modeling and in vitro reactivation study between the oxime BI-6 and acetylcholinesterase inhibited by different nerve agents. J Biomol Struct Dyn. 2015;33(9):2048–2058. doi:10.1080/07391102.2014.989408.
   PubMed Web of Science ®Google Scholar
• Kuca K, Musilek K, Jun D, et al. A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase. BMC Pharmacol Toxicol. 2018;19(1):8. doi:10.1186/s40360-018-0196-3.
   PubMedGoogle Scholar